期刊文献+

青光眼手术前后口服醋甲唑胺致Stevens—Johnson综合征 被引量:1

Methazolamide-induced Stevens-Johnson syndrome before and after glaucoma surgery
原文传递
导出
摘要 目的分析青光眼手术前后口服醋甲唑胺引起Stevens—Johnson综合征的临床特点。方法回顾性分析2例因口服醋甲唑胺致药源性Stevens-Johnson综合征的发病过程、皮疹特点、治疗经过及结果。结果醋甲唑胺可能引起药源性Stevens-Johnson综合征,用药后lO余天出现口腔、眼及生殖器等黏膜受损、糜烂,伴全身皮疹,继而出现水疱、大疱、表皮松解剥脱。治疗停用可疑致敏药物,给予全身皮质类固醇、人免疫球蛋白,全身支持治疗及黏膜护理等综合治疗。结论醋甲唑胺降眼压效果良好,但要警惕其可能引起的严重皮肤黏膜变态反应,可能危及生命,需严格掌握用药禁忌证,做好用药前沟通和用药后监护,早期发现皮肤黏膜损害,及时全身综合治疔和护理,尽可能降低危害。 Objective To analyse the clinical characteristics of Stevens-Johnson syndrome induced hy using methazolamide before and after glaucoma surgery. Methods The course of disease,rash characteristics, treatment and therapeutic outcome of two patients of methazolamide-induced Stevens-Johnson syndrome were retrospectively analysed. Results Methazolamide may cause drug-induced Stevens-Johnson syndrome. After 10 days of using it, oral, eye and genital mucosa damaged and got erosion with whole body skin rash. Then a blister, bullosa occurred and epidermolysis stripped. Suspicious allergenic drugs were discontinued. Systemic corticosteroids, immune globulin, the whole body support treatment, mucous membrane care and other comprehensive treatment were given. Conclusion Methazolamide is effective on introcular pressure reduction, but may cause severe skin and mucosa allergy which is life-threatening. So the medical contraindications should be controlled strictly and good communication with patients is also important before treatment. The early detection of skin mucous membrane damage and timely systemic comprehensive treatment is very important.
出处 《中华眼外伤职业眼病杂志》 2014年第11期850-852,共3页 Chinese Journal of Ocular Trauma and Occupational Eye Disease
关键词 醋甲唑胺 STEVENS-JOHNSON综合征 药物不良反应 Methazolamide Syndrome, Stevens - Johnson Reaction, drug, adverse
  • 相关文献

参考文献11

  • 1许晖,姚全胜,周国林.醋甲唑胺降低兔眼内压的研究[J].中华眼科杂志,1999,35(1):55-57. 被引量:7
  • 2Mockenhaupt M. The current understanding of Stevens-Johnsonsyndrome and toxic epidermal necrolysis[ J]. Expert Rev Clin Im-munol, 2011, 7:803-813.
  • 3Flach AJ,Smith RE,Fraunfelder FT. Stevens-Johnson syndromeassociated with methazolamide treatment reported in two Japanese-American women[ J]. Ophthalmology, 1995 , 102 : 1677-1680.
  • 4Shirato S, Kagaya F, Suzuki Y, et al. Stevens-Johnson syndromeinduced by methazolamide treatment [ J ]. Arch Ophthalmol,1997,115: 550-553.
  • 5Borchers AT, Lee JL, Naguwa SM, et al. Stevens-Johnson syn-drome (SJS ) and toxic epidermal necrolysis [ J ]. Autoimmun Rev,2008, 7: 598-605.
  • 6何学莲,王芳琳,吴革菲,孙丹,康世秀,胡家胜,毛冰,何彩英,刘智胜.奥卡西平诱发的Stevens-Johnson综合征的临床特点及基因表达[J].实用儿科临床杂志,2011,26(5):360-362. 被引量:17
  • 7Hung SI, Chung WH, Liu ZS,et al. Common risk allele in aro-matic antiepileptic-drug induced Stevens-Johnson syndrome andtoxic epidermal necrolysis in Han Chinese [ J ]. Pharmacogenom-ics, 2010, 11: 349-356.
  • 8Kulkantrakom K, Tassaneeyakul W, Tiamkao S, et al. HLA-B1502 strongly predicts carbamazepine-induced Stevens-Johnsonsyndrome and toxic epidermal necrolysis in Thai patients with neu-ropathic pain[ J]. Pain Pract,2012, 12: 202-208.
  • 9Kim SH, Kim M, Lee KW, et al. HLA-B *5901 is strongly asso-ciated with methazolamide-induced Stevens-Johnson syndrome/tox-ic epidermal necrolysis[ J]. Pharmacogenomics, 2010,11: 879-884.
  • 10金如钧,章晓阳,江建雄,孙丽萍.甲醋唑胺诱发Stevens-Johnson综合征1例[J].中国皮肤性病学杂志,2012,26(4):363-364. 被引量:6

二级参考文献43

  • 1Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine - induced cutaneous adverse drug reactions [ J ]. Pharmacogenet Gertomics,2006,16 (4) : 297 - 306.
  • 2Tassaneeyakul W,Tiamkao S, Jantararoungtong T,et al. Association between HLA - B * 1502 and carbamazepine - induced severe cutaneous adverse drug reactions in a Thai population [ J ]. Epilepsia, 2010,51 (5) :926 -930.
  • 3Htmg SI, Chtmg WH, Liou LB,et al. HLA - B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol [ J]. Proc Natl Acad Sci USA,2005,102( 11 ):4134-4139.
  • 4I Kaniwa N ,Saito Y ,Aihara M,et al. HLA - B locus in Japanese patients with anti - epileptics and allopurinol - related Stevens - Johnson syndrome and toxic epidermal necrolysis [ J ]. Pharmacogenomics, 2008,9 (11) :1617 -1622.
  • 5Tassaneeyakul W,Jantararoungtong T,Chen P,et al. Strong association between HLA - B * 5801 and allopurinol - induced Stevens - Johnson syndrome and toxic epidermal necrolysis in a Thai population [ J ]. Pharmacogenet Genomics ,2009,19(9 ) :704 - 709.
  • 6Lonjou C,Borot N,Sekula P,et al. A European study of HLA -B in Stevens- Johnson syndrome and toxic epidermal necrolysis related to five high - risk drugs [ J ]. Pharmacogenet Genomics, 2008,18 ( 2 ) : 99 - 107.
  • 7Wu XT, Hu FY, An DM,et al. Association between earbamazepine -induced cutaneous adverse drug reactions and the HLA - B * 1502 allele among patients in central China[ J ]. Epilepsy Behav ,2010,19 (3) :405 - 408.
  • 8Locharernkul C, Loplumlert J, Limotai C,et al. Carbamazepine and phenytoin induced Stevens - Johnson syndrome is associated with HLAB * 1502 allele in Thai population [ J ]. Epilepsia. 2008,49 ( 12 ) : 2087 - 2091.
  • 9Lonjou C, Thomas L, Borot N, et al. A marker for Stevens - Johnson syndrome ethnicity matters[ J ]. Pharmacogenomics J,2006,6(4) :265 - 268.
  • 10An DM, Wu XT, Hu FY, et al. Association study of lamotrigine - induced cutaneous adverse reactions and HLA - B * 1502 in a Han Chi- nese population [ J ]. Epilepsy Res ,2010 ,92 (2 - 3 ) :226 - 230.

共引文献31

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部